EP3052077B1 - Topische präparate mit traubenkernextrakt - Google Patents

Topische präparate mit traubenkernextrakt Download PDF

Info

Publication number
EP3052077B1
EP3052077B1 EP14850602.5A EP14850602A EP3052077B1 EP 3052077 B1 EP3052077 B1 EP 3052077B1 EP 14850602 A EP14850602 A EP 14850602A EP 3052077 B1 EP3052077 B1 EP 3052077B1
Authority
EP
European Patent Office
Prior art keywords
extract
grape seed
biotin
vary
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP14850602.5A
Other languages
English (en)
French (fr)
Other versions
EP3052077A4 (de
EP3052077A1 (de
Inventor
Wilson A. Lee
Barbara A. CROCKETT
Edward Pelle
Nadine A. Pernodet
Georgena M. KEUPP
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ELC Management LLC
Original Assignee
ELC Management LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ELC Management LLC filed Critical ELC Management LLC
Publication of EP3052077A1 publication Critical patent/EP3052077A1/de
Publication of EP3052077A4 publication Critical patent/EP3052077A4/de
Application granted granted Critical
Publication of EP3052077B1 publication Critical patent/EP3052077B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Definitions

  • the invention is in the field of skin care, specifically directed to topical products comprising grape seed and at least some of folic acid, biotin, Bifidobacterium longum extract and Echinacea purpurea.
  • Grape seed extracts are also used as emollients, emulsifiers and a skin conditioning agents (see for example "Vitis vinifera (Grape) Ingredients as Used in Cosmetics", retrievable from the Internet under URL http://www.cir-safety.org/sites/ default/files/vitis022012SLR_for%20posting.pdf).
  • Folic acid ( CAS 59-30-3 ) is an organic compound with formula (C 19 H 19 N 7 O 6 ): Folic acid is used in topical preparations as a skin conditioning agent.
  • Biotin ( CAS 58-85-5 ) is known to be used as a hair and skin conditioning agent in topical formulations, such shampoo, conditioner, soap, bath oils and salts, and makeup.
  • Biotin is a carboxylic acid of the formula (C 10 H 16 N 2 O 3 S):
  • Bifidus or Bifida ferment extract is an extract obtained from the fermentation of Bifidobacterium longum. It has been used as a skin conditioning agent and humectant. It is also reported to promote the DNA repair process of skin cells.
  • US4,464,362 discloses the topical use of species Bifidobacterium longum (Reuter) to treat photodamage.
  • Echinacea purpurea (Coneflower) extract is known to be used in topical compositions, including hair products, where it is reported to possess anti-bacterial and anti-inflammatory activity. Echinacea purpurea, should not be confused with Echinacea angustifolia, Echinacea pallid and other varieties of Echinacea.
  • compositions comprising grape seed extract and one or more of folic acid, biotin, bifidus, and Echinacea purpurea have widely varying antioxidant activities.
  • Each of these ingredients offers useful benefits in the battle against environmentally induced skin damage.
  • the present invention thus relates to topical compositions comprising grape seed extract, as described in the claims.
  • the antioxidation activity of various topical preparations was measured with the following assay.
  • Each topical composition to be tested is diluted to 1% in isopropyl alcohol. Typically, 50-100 ⁇ l of this dilution is further diluted with water up to 250 ⁇ l.
  • Percent inhibition of oxidation is calculated as (dA control - dA product /dA control ) x 100 and used to quantitate IC 50 values, where dA is the change in absorbance over two minutes. 15 to 85 nanomoles of an antioxidant standard (AO std; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) are used to determine the relative activity of a test sample.
  • AO std 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
  • Tables 1a and 1b show eleven formulae that were tested for anti-oxidant activity according to the assay described above.
  • the base formula labeled "Control” offers 0% antioxidant activity.
  • Formula 8 which is the base formula plus 0.05% grape seed extract (a known antioxidant), offers about 17.5% inhibition of oxidation.
  • a topical composition comprising grape seed extract and a combination of folic acid and bifidus, but not the combination of biotin and Echinacea purpurea.
  • a topical composition comprising grape seed extract and a combination of folic acid and bifidus, but not the combination of biotin and Echinacea purpurea.
  • a topical composition comprising grape seed extract and a combination of biotin and Echinacea purpurea, but not the combination of folic acid and bifidus.
  • a topical composition comprising grape seed extract and a combination of biotin and bifidus, but not the combination of folic acid/ Echinacea purpurea.
  • a topical composition comprising grape seed extract and a combination of folic acid and Echinacea purpurea, but not the combination of biotin and bifidus.
  • compositions comprising grape seed extract the combination of exactly three of the following: folic acid, biotin, bifidus and Echinacea purpurea is useful; the combination of biotin, bifidus and Echinacea purpurea (without folic acid) is preferred, as is the combination of folic acid, bifidus and Echinacea purpurea (without biotin); the combination of folic acid, biotin and bifidus (without Echinacea purpurea ) is more preferred; and the combination of folic acid, biotin and Echinacea purpurea (without bifidus, formula 5, for example) is most preferred.
  • compositions of the present invention the relative concentrations of certain ingredients are selected according to the following:
  • the most preferred ratio of concentrations of folic acid to biotin to grape seed to Echinacea purpurea to bifidus extract is 1 : 1 : 50 : 100 : 10,000, with no more than 10% variation in any of the ingredients. This may be written as: 0.9 - 1.1 : 0.9 - 1.1 : 45 - 55 : 90 - 110 : 9,000 - 11,000 (folic acid : biotin : grape seed : Echinacea purpurea : bifidus extract).
  • one exemplary ratio would be: 0.001 gm of folic acid, 0.001 gm of biotin, 0.05 gm of grape seed extract, 0.10 gm of Echinacea purpurea and 10.0 gm of bifidus extract.
  • compositions according to the present invention may be implemented as skin care preparations, hair care preparations, or as color cosmetics.
  • Color cosmetics include blush, eyeshadow, lipstick, lip gloss, foundation, concealer, and the like, for altering the appearance of the skin.
  • Compositions according to the present invention may be implemented as lotions, creams toners, gels, solid or semi-solid preparations.
  • Skin care preparations include those that target the face, hands, and scalp.
  • Hair care preparations include those that target the hair of the head or the eyelashes.
  • Compositions may be in the form of emulsions, suspensions or mixtures.
  • compositions may contain virtually any cosmetically acceptable ingredients.
  • Many hair and /or skin conditioning agents may be mentioned, but for scalp products the following are especially useful: adenosine phosphate, aloe barbadensis, Arabidopsis thaliana extract, arginine, butylene glycol, caffeine, caprylyl glycol, carrageenan, ethylhexylglycerine, soybean extract, hydrolyzed wheat protein, lactobacillus ferment, laminaria saccharina extract, panthenine, pullulan, quinoa seed extract, rosemary leaf extract, saccharomyces lysate extract, sodium RNA fragments, yeast extract.
  • These may typically be used at concentrations 0.0001 to 5.0% by weight of the final composition. It is preferred to use at least three of these for an effective scalp treatment. At least five of these is more preferred for addressing the needs of the scalp.
  • Useful solvents include water and/or alcohol. Total solvents may typically comprise 60% - 90% of the composition by weight. Alcohol may typically range from 0% - 20% by weight of the composition.
  • Useful preservatives include benzoic acid, chlorphenesin, phenoxyethanol, potassium sorbate, sodium benzoate, sodium dehydroacetate and sorbic acid. Total preservatives may range from 0.01% to 5.0% by weight of the composition.
  • the composition may comprise: emulsion facilitators such as ammonium acryloyldimethyltaurate / Benheneth-25 methacrylate crosspolymer and lecithin; pH adjusters, such as ammonium stearate; humectants such as panthenol and saccharide isomerate; binders, such as hydrogenated castor oil; bulking agents, such as silica; absorbents, such as maltodextrin; antioxidants (other than grape seed extract), such as tocopherol.
  • emulsion facilitators such as ammonium acryloyldimethyltaurate / Benheneth-25 methacrylate crosspolymer and lecithin
  • pH adjusters such as ammonium stearate
  • humectants such as panthenol and saccharide isomerate
  • binders such as hydrogenated castor oil
  • bulking agents such as silica
  • absorbents such as maltodextrin
  • antioxidants
  • Example 1 Example 2
  • Example 3 Example 4 alcohol -- -- 15.000 -- water/chondrus crispus extract 3.000 3.000 2.500 3.000 pullulan 0.100 0.100 0.100 0.100 aloe vera powder 0.010 0.100 0.001 0.001 hydrolyzed wheat protein 0.010 0.010 0.500 0.500 hydrolyzed soy protein -- -- 0.500 0.500 quinoa protein 0.010 0.010 -- -- folic acid 0.001 0.001 0.001 biotin 0.001 0.001 0.001 0.001 vitis vinifera (grape) seed extract 0.050 0.050 0.050 0.100 panthenol 0.100 0.100 0.200 0.200 sodium dehydroacetate 0.200 0.200 -- -- silica 0.060 0.050 -- -- saccharide isomerate 0.500 0.500 -- -- bifida ferment lysate 10.000 10.000 10.000 10.000 gly
  • Examples 1 - 4 (not according to the present invention) have grape seed plus the four actives, folic acid, biotin, bifidus and Echinacea purpurea.
  • Examples according to the present invention may be created by removing any one of folic acid, biotin, bifidus or Echinacea purpurea from examples 1 - 4, while retaining the other three. Additional examples may also be created by varying the relative concentrations of grape seed, folic acid, biotin, bifidus and Echinacea purpurea within the guidelines for relative concentration presented above.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (11)

  1. Topische Zusammensetzung umfassend Traubenkernextrakt und genau drei der Folgenden: Folsäure, Biotin, Bifidus-Fermentextrakt und Purpur-Sonnenhut.
  2. Zusammensetzung nach Anspruch 1, umfassend Folsäure, Biotin und Bifidus-Fermentextrakt.
  3. Zusammensetzung nach Anspruch 2, wobei die folgenden relativen Konzentrationen eingehalten werden:
    das Verhältnis von Traubenkern zu Folsäure kann von 50:0 bis 50:1 variieren;
    das Verhältnis von Traubenkern zu Biotin kann von 50:0 bis 50:1 variieren; und
    das Verhältnis von Traubenkern zu Bifidus-Extrakt kann von 50:0 bis 50:10.000 variieren.
  4. Zusammensetzung nach Anspruch 1 umfassend Folsäure, Biotin und Purpur-Sonnenhut.
  5. Zusammensetzung nach Anspruch 4, wobei die folgenden relativen Konzentrationen eingehalten werden:
    das Verhältnis von Traubenkern zu Folsäure kann von 50:0 bis 50:1 variieren;
    das Verhältnis von Traubenkern zu Biotin kann von 50:0 bis 50:1 variieren; und
    das Verhältnis von Traubenkern zu Purpur-Sonnenhut kann von 50:0 bis 50:100 variieren.
  6. Zusammensetzung nach Anspruch 1 umfassend Folsäure, Bifidus-Fermentextrakt und Purpur-Sonnenhut.
  7. Zusammensetzung nach Anspruch 6, wobei die folgenden relativen Konzentrationen eingehalten werden:
    das Verhältnis von Traubenkern zu Folsäure kann von 50:0 bis 50:1 variieren;
    das Verhältnis von Traubenkern zu Purpur-Sonnenhut kann von 50:0 bis 50:100 variieren; und
    das Verhältnis von Traubenkern zu Bifidus-Extrakt kann von 50:0 bis 50:10.000 variieren.
  8. Zusammensetzung nach Anspruch 1, umfassend Biotin, Bifidus-Fermentextrakt und Purpur-Sonnenhut.
  9. Zusammensetzung nach Anspruch 8, wobei die folgenden relativen Konzentrationen eingehalten werden:
    das Verhältnis von Traubenkern zu Biotin kann von 50:0 bis 50:1 variieren;
    das Verhältnis von Traubenkern zu Purpur-Sonnenhut kann von 50:0 bis 50:100 variieren; und
    das Verhältnis von Traubenkern zu Bifidus-Extrakt kann von 50:0 bis 50:10.000 variieren.
  10. Topische Zusammensetzung nach Anspruch 1, ferner Folgendes umfassend:
    mindestens drei der folgenden Konditioniermittel in Konzentrationen von 0,001 bis 5,0 Gew.-% der endgültigen Zusammensetzung: Adenosinphosphat, Aloe barbadensis, Arabidopsis thaliana-Extrakt, Arginin, Butylenglycol, Coffein, Caprylylglycol, Carrageen, Ethylhexylglycerin, Sojabohnenextrakt, hydrolysiertes Weizenprotein, Lactobacillus-Ferment, Laminaria saccharina-Extrakt, Panthenin, Pullulan, Quinoakörnerextrakt, Rosmarinblätterextrakt, Saccharomyceslysat-Extrakt, Natrium-RNA-Fragmente, Hefeextrakt.
  11. Topische Zusammensetzung nach Anspruch 10, umfassend mindestens fünf der Konditioniermittel.
EP14850602.5A 2013-10-03 2014-09-30 Topische präparate mit traubenkernextrakt Active EP3052077B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/045,487 US20150098934A1 (en) 2013-10-03 2013-10-03 Topical Preparations Comprising Grape Seed, Folic Acid, Biotin, Bifidobacterium longum and Echinacea purpurea
PCT/US2014/058360 WO2015050883A1 (en) 2013-10-03 2014-09-30 Topical preparations comprising grape seed, folic acid, biotin, bifidobacterium longum and echinacea purpurea

Publications (3)

Publication Number Publication Date
EP3052077A1 EP3052077A1 (de) 2016-08-10
EP3052077A4 EP3052077A4 (de) 2017-04-26
EP3052077B1 true EP3052077B1 (de) 2018-09-19

Family

ID=52777118

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14850602.5A Active EP3052077B1 (de) 2013-10-03 2014-09-30 Topische präparate mit traubenkernextrakt

Country Status (8)

Country Link
US (1) US20150098934A1 (de)
EP (1) EP3052077B1 (de)
JP (1) JP6138361B2 (de)
KR (1) KR101910258B1 (de)
AU (1) AU2014329745A1 (de)
CA (1) CA2923250C (de)
ES (1) ES2697756T3 (de)
WO (1) WO2015050883A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10383815B2 (en) 2012-09-14 2019-08-20 Elc Management Llc Method and compositions for improving selective catabolysis in cells of keratin surfaces
AU2016321396B2 (en) * 2015-09-11 2021-12-23 Wm. Wrigley Jr. Company Synergistic antibacterial effects of magnolia bark extract and L-arginine, N-alpha-lauroyl ethyl ester on plaque biofilm
JP2021515747A (ja) * 2018-03-05 2021-06-24 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 局所用組成物
PL236460B1 (pl) * 2018-04-04 2021-01-25 Dabrowska Mas Elzbieta Kompozycja priobiotyczna zawierająca priobiotyk, składnik detoksykacyjny i kofeinę
CN109172432A (zh) * 2018-09-27 2019-01-11 广州航美化妆品有限公司 保湿修复组合物及其应用
CN110051590A (zh) * 2019-05-22 2019-07-26 广州睿森生物科技有限公司 美白淡斑组合物以及含有该组合物的化妆品
CN112842987A (zh) * 2021-03-23 2021-05-28 国珍健康科技（北京）有限公司 美白功效组合物及其制备方法和应用、美白精华
FR3125717A1 (fr) * 2021-07-30 2023-02-03 L'oreal Composition comprenant au moins 0,5% en poids d’agent antioxydant, un lysat de Bifidobacterium species et un extrait de levure
CN115227632B (zh) * 2022-08-03 2024-04-26 广东馨柯生命科学有限公司 一种富含牡丹提取物Essenpure PRE的消炎抗菌的温和洁面慕斯及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITBS20010027A1 (it) * 2001-03-23 2002-09-23 Gen Topics Srl Principio attivo a base di acido lipoico ed acidi grassi polienolici
WO2004067678A1 (ja) * 2003-01-27 2004-08-12 Mitsubishi Corporation 抗酸化組成物と外用組成物
KR101060634B1 (ko) * 2005-10-05 2011-08-31 에자끼구리고가부시키가이샤 인산화당을 함유한 피부외용제
US20070202215A1 (en) * 2006-02-28 2007-08-30 Zahramehran Salari Lak Dietary nutritional supplements for persons consuming alcohol products
US20090110674A1 (en) * 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
US8257694B2 (en) * 2009-05-14 2012-09-04 Product Partners, Llc Nutritional compositions for reducing oxidative damage
US20110206721A1 (en) * 2010-02-19 2011-08-25 Vijaya Nair Fermented soy nutritional supplements including mushroom components
CA2834765A1 (en) * 2011-04-29 2012-11-01 Photomedex, Inc. Topical dna repair compositions
KR20170012588A (ko) * 2011-10-11 2017-02-02 이엘씨 매니지먼트 엘엘씨 피부를 처리하기 위한 방법 및 조성물
CN102755281A (zh) * 2012-07-13 2012-10-31 无锡紫昂生物科技有限公司 一种含有微生物调节剂的化妆品
AU2013371414B2 (en) * 2013-01-07 2016-11-03 Elc Management Llc Method and compositions for improving selective catabolysis and viability in cells of keratin surfaces

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
KR101910258B1 (ko) 2018-10-19
CA2923250A1 (en) 2015-04-09
WO2015050883A1 (en) 2015-04-09
AU2014329745A1 (en) 2016-04-14
EP3052077A4 (de) 2017-04-26
ES2697756T3 (es) 2019-01-28
KR20160048207A (ko) 2016-05-03
CA2923250C (en) 2017-08-29
EP3052077A1 (de) 2016-08-10
US20150098934A1 (en) 2015-04-09
JP6138361B2 (ja) 2017-05-31
JP2016531887A (ja) 2016-10-13

Similar Documents

Publication Publication Date Title
EP3052077B1 (de) Topische präparate mit traubenkernextrakt
JP2001122765A (ja) 活性酸素消去剤および化粧料
KR101709734B1 (ko) 홍국 추출물을 함유하는 보습용 피부 외용제 조성물
KR102085422B1 (ko) 강황 추출물과 동백 오일을 함유하는 화장료 조성물 및 피부 외용제 조성물
CN107809998B (zh) 柔毛肖乳香的水醇提取物、包含其的化妆品组合物及其美容用途
KR102253095B1 (ko) 여드름 피부 개선 화장료, 이의 제조방법 및 이를 포함하는 여드름 피부 개선 기능성 화장품
CN107753332A (zh) 一种多效油膏
JP2001122758A (ja) ＡＧＥｓ分解作用を有する老化肌防御、改善化粧料
WO2020264567A1 (en) Skin care composition
KR20150138942A (ko) 송이 분말과 선인장 추출물을 이용한 클렌징 화장료 조성물
JP2004131498A (ja) 皮膚外用剤
KR20230135528A (ko) 아스타잔틴, 표피성장인자 및 천연물 복합 추출물을 유효성분으로 포함하는 화장료 조성물
JP2000128729A (ja) 化粧料
JP4045160B2 (ja) 皮膚外用剤
AU2020405221A1 (en) Personal care compositions and methods for the same
JP3885243B2 (ja) 皮膚化粧料
KR20190092686A (ko) 혼합 추출물을 유효성분으로 함유하는 미백용 화장료 조성물 및 화장품 조성물, 그리고 미백용 화장물 조성물 및 화장품 조성물의 제조 방법
KR102632674B1 (ko) 해조류 추출물을 포함한 피부 항산화 및 향균성 화장료 조성물 및 이를 포함하는 젤
JP2005343843A (ja) 黒砂糖エキス及びダイズエキスを含有する化粧料組成物
JP7117772B2 (ja) 皮膚老化防止剤及びエラスターゼ阻害活性剤の製造方法
WO2023148428A1 (en) Use of nordic plant-based ingredients for supporting a healthy skin microbiome
JPWO2005084613A1 (ja) 皮膚外用剤
KR20230017683A (ko) 피부장벽 및 염증 개선 효과를 갖는 화장료 조성물
EP3954358A1 (de) Kosmetikkomplex und verwendungen davon
JP2005060329A (ja) 化粧料

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160331

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20170329

RIC1 Information provided on ipc code assigned before grant

Ipc: A61Q 19/00 20060101ALI20170320BHEP

Ipc: A61K 8/99 20170101ALI20170320BHEP

Ipc: A61K 8/30 20060101ALI20170320BHEP

Ipc: A61K 8/97 20170101AFI20170320BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20180430

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1042415

Country of ref document: AT

Kind code of ref document: T

Effective date: 20181015

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602014032738

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 5

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20180919

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2697756

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20190128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181219

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181220

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181219

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1042415

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180919

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190119

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190119

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20180930

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602014032738

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180930

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180930

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

26N No opposition filed

Effective date: 20190620

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180930

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180930

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20140930

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180919

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180919

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20230920

Year of fee payment: 10

Ref country code: GB

Payment date: 20230926

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230926

Year of fee payment: 10

Ref country code: DE

Payment date: 20230928

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20231018

Year of fee payment: 10